Baldini N - Search Results

1

Murine model for skeletal metastases of Ewing's sarcoma.

Scotlandi K, Benini S, Manara MC, Serra M, Nanni P, Lollini PL, Nicoletti G, Landuzzi L, Chano T, Picci P, Baldini N. Scotlandi K, et al. Among authors: baldini n. J Orthop Res. 2000 Nov;18(6):959-66. doi: 10.1002/jor.1100180616. J Orthop Res. 2000. PMID: 11192257

2

Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells.

Scotlandi K, Maini C, Manara MC, Benini S, Serra M, Cerisano V, Strammiello R, Baldini N, Lollini PL, Nanni P, Nicoletti G, Picci P. Scotlandi K, et al. Among authors: baldini n. Cancer Gene Ther. 2002 Mar;9(3):296-307. doi: 10.1038/sj.cgt.7700442. Cancer Gene Ther. 2002. PMID: 11896447

3

Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor.

Scotlandi K, Serra M, Manara MC, Benini S, Sarti M, Maurici D, Lollini PL, Picci P, Bertoni F, Baldini N. Scotlandi K, et al. Among authors: baldini n. Hum Pathol. 1996 Apr;27(4):408-16. doi: 10.1016/s0046-8177(96)90115-x. Hum Pathol. 1996. PMID: 8617485

4

Multidrug resistance and malignancy in human osteosarcoma.

Scotlandi K, Serra M, Nicoletti G, Vaccari M, Manara MC, Nini G, Landuzzi L, Colacci A, Bacci G, Bertoni F, Picci P, Campanacci M, Baldini N. Scotlandi K, et al. Among authors: baldini n. Cancer Res. 1996 May 15;56(10):2434-9. Cancer Res. 1996. PMID: 8625324

5

Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target.

Scotlandi K, Benini S, Sarti M, Serra M, Lollini PL, Maurici D, Picci P, Manara MC, Baldini N. Scotlandi K, et al. Among authors: baldini n. Cancer Res. 1996 Oct 15;56(20):4570-4. Cancer Res. 1996. PMID: 8840962

6

Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.

Lollini PL, Landuzzi L, Frabetti F, Rossi I, Nicoletti G, Scotlandi K, Serra M, Baldini N, De Giovanni C, Nanni P. Lollini PL, et al. Among authors: baldini n. Clin Cancer Res. 1998 Aug;4(8):1843-9. Clin Cancer Res. 1998. PMID: 9717810

7

Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice.

Scotlandi K, Benini S, Nanni P, Lollini PL, Nicoletti G, Landuzzi L, Serra M, Manara MC, Picci P, Baldini N. Scotlandi K, et al. Among authors: baldini n. Cancer Res. 1998 Sep 15;58(18):4127-31. Cancer Res. 1998. PMID: 9751624

8

P-glycoprotein expression in osteosarcoma: a basis for risk-adapted adjuvant chemotherapy.

Baldini N, Scotlandi K, Serra M, Picci P, Bacci G, Sottili S, Campanacci M. Baldini N, et al. J Orthop Res. 1999 Sep;17(5):629-32. doi: 10.1002/jor.1100170502. J Orthop Res. 1999. PMID: 10569469

9

CD99 engagement: an effective therapeutic strategy for Ewing tumors.

Scotlandi K, Baldini N, Cerisano V, Manara MC, Benini S, Serra M, Lollini PL, Nanni P, Nicoletti G, Bernard G, Bernard A, Picci P. Scotlandi K, et al. Among authors: baldini n. Cancer Res. 2000 Sep 15;60(18):5134-42. Cancer Res. 2000. PMID: 11016640

10

Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.

Benini S, Manara MC, Baldini N, Cerisano V, Massimo Serra, Mercuri M, Lollini PL, Nanni P, Picci P, Scotlandi K. Benini S, et al. Among authors: baldini n. Clin Cancer Res. 2001 Jun;7(6):1790-7. Clin Cancer Res. 2001. PMID: 11410521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page